ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Protein Therapeutics Drugs Market Research Report 2025
Published Date: 2025-12-19
|
Report Code: QYRE-Auto-20K20265
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Protein Therapeutics Drugs Market Outlook In Depth Analysis Forecast to 2031
BUY CHAPTERS

Global Protein Therapeutics Drugs Market Research Report 2025

Code: QYRE-Auto-20K20265
Report
2025-12-19
Pages:111
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson and Johnson
Pfizer Inc
F Hoffmann La Roche Ltd
Novo Nordisk AS
Sanofi
Amgen Inc
Merck and Co Inc
Abbott Laboratories
Baxter International Inc
Eli Lilly and Company
AbbVie
Novartis
Gilead Sciences
Bristol–Myers Squibb
Innovent
Astrazeneca plc
Hengrui Medicine
Takeda
Kanghong Pharma
Seagen
SOBI

Protein Therapeutics Drugs Market Size

The global market for Protein Therapeutics Drugs was valued at US$ 315010 million in the year 2024 and is projected to reach a revised size of US$ 512330 million by 2031, growing at a CAGR of 7.3% during the forecast period.

Protein Therapeutics Drugs Market

Protein Therapeutics Drugs Market

Protein Therapeutics Drugs are a type of medicine that are used to treat a variety of diseases such as cancer, metabolic, immunological, hematological, hormonal, genetic, infectious diseases, and others. These drugs have the potential to significantly improve human health. In principle, protein therapy is similar to gene therapy; which involves protein delivery in specific amounts to the body to facilitate precise functioning of different glands and other organs in the body
Growth of the protein therapeutics market is majorly driven by rise in prevalence of chronic diseases and development of plasma-derived therapies. Increase in prevalence of various diseases such as cancer, metabolic disorders, genetic disorders, and immunological diseases are expected to propel demand for protein therapeutics. In addition, according to the World Health Organization (WHO), cancer is a leading cause of death worldwide, and cancer cases are expected to increase significantly in the future. Thus, rise in prevalence of cancer is anticipated to drive the protein therapeutics market.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Protein Therapeutics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Therapeutics Drugs.
The Protein Therapeutics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Dose) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Protein Therapeutics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Protein Therapeutics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Protein Therapeutics Drugs Market Report

Report Metric Details
Report Name Protein Therapeutics Drugs Market
Accounted market size in year US$ 315010 million
Forecasted market size in 2031 US$ 512330 million
CAGR 7.3%
Base Year year
Forecasted years 2026 - 2031
Segment by Type
  • Monoclonal Antibodies
  • Insulin
  • Fusion Protein
  • Erythropoietin
  • Interferon
  • Human Growth Hormone
  • Others
Segment by Application
  • Cancer
  • Metabolic Disorders
  • Immunologic Disorders
  • Hematological Disorders
  • Hormonal Disorders
  • Genetic Disorders
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Johnson and Johnson, Pfizer Inc, F. Hoffmann La Roche Ltd, Novo Nordisk AS, Sanofi, Amgen Inc, Merck and Co., Inc, Abbott Laboratories, Baxter International Inc, Eli Lilly And Company, AbbVie, Novartis, Gilead Sciences, Bristol-Myers Squibb, Innovent, AstraZeneca, Hengrui Medicine, Takeda, Kanghong Pharma, Seagen, Sobi
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Protein Therapeutics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Protein Therapeutics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Protein Therapeutics Drugs Market growing?

Ans: The Protein Therapeutics Drugs Market witnessing a CAGR of 7.3% during the forecast period 2026-2031.

What is the Protein Therapeutics Drugs Market size in 2031?

Ans: The Protein Therapeutics Drugs Market size in 2031 will be US$ 512330 million.

Who are the main players in the Protein Therapeutics Drugs Market report?

Ans: The main players in the Protein Therapeutics Drugs Market are Johnson and Johnson, Pfizer Inc, F. Hoffmann La Roche Ltd, Novo Nordisk AS, Sanofi, Amgen Inc, Merck and Co., Inc, Abbott Laboratories, Baxter International Inc, Eli Lilly And Company, AbbVie, Novartis, Gilead Sciences, Bristol-Myers Squibb, Innovent, AstraZeneca, Hengrui Medicine, Takeda, Kanghong Pharma, Seagen, Sobi

What are the Application segmentation covered in the Protein Therapeutics Drugs Market report?

Ans: The Applications covered in the Protein Therapeutics Drugs Market report are Cancer, Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Hormonal Disorders, Genetic Disorders, Others

What are the Type segmentation covered in the Protein Therapeutics Drugs Market report?

Ans: The Types covered in the Protein Therapeutics Drugs Market report are Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, Others

1 Protein Therapeutics Drugs Market Overview
1.1 Product Definition
1.2 Protein Therapeutics Drugs by Type
1.2.1 Global Protein Therapeutics Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 Monoclonal Antibodies
1.2.3 Insulin
1.2.4 Fusion Protein
1.2.5 Erythropoietin
1.2.6 Interferon
1.2.7 Human Growth Hormone
1.2.8 Others
1.3 Protein Therapeutics Drugs by Application
1.3.1 Global Protein Therapeutics Drugs Market Value by Application (2024 VS 2031)
1.3.2 Cancer
1.3.3 Metabolic Disorders
1.3.4 Immunologic Disorders
1.3.5 Hematological Disorders
1.3.6 Hormonal Disorders
1.3.7 Genetic Disorders
1.3.8 Others
1.4 Global Protein Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Protein Therapeutics Drugs Revenue 2020-2031
1.4.2 Global Protein Therapeutics Drugs Sales 2020-2031
1.4.3 Global Protein Therapeutics Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Protein Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Protein Therapeutics Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Protein Therapeutics Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Protein Therapeutics Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Protein Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Protein Therapeutics Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Protein Therapeutics Drugs, Product Type & Application
2.7 Global Key Manufacturers of Protein Therapeutics Drugs, Date of Enter into This Industry
2.8 Global Protein Therapeutics Drugs Market Competitive Situation and Trends
2.8.1 Global Protein Therapeutics Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Protein Therapeutics Drugs Players Market Share by Revenue
2.8.3 Global Protein Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Protein Therapeutics Drugs Market Scenario by Region
3.1 Global Protein Therapeutics Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Protein Therapeutics Drugs Sales by Region: 2020-2031
3.2.1 Global Protein Therapeutics Drugs Sales by Region: 2020-2025
3.2.2 Global Protein Therapeutics Drugs Sales by Region: 2026-2031
3.3 Global Protein Therapeutics Drugs Revenue by Region: 2020-2031
3.3.1 Global Protein Therapeutics Drugs Revenue by Region: 2020-2025
3.3.2 Global Protein Therapeutics Drugs Revenue by Region: 2026-2031
3.4 North America Protein Therapeutics Drugs Market Facts & Figures by Country
3.4.1 North America Protein Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Protein Therapeutics Drugs Sales by Country (2020-2031)
3.4.3 North America Protein Therapeutics Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Protein Therapeutics Drugs Market Facts & Figures by Country
3.5.1 Europe Protein Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Protein Therapeutics Drugs Sales by Country (2020-2031)
3.5.3 Europe Protein Therapeutics Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Protein Therapeutics Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Protein Therapeutics Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Protein Therapeutics Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Protein Therapeutics Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Protein Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Latin America Protein Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Protein Therapeutics Drugs Sales by Country (2020-2031)
3.7.3 Latin America Protein Therapeutics Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Protein Therapeutics Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Protein Therapeutics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Protein Therapeutics Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Protein Therapeutics Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Protein Therapeutics Drugs Sales by Type (2020-2031)
4.1.1 Global Protein Therapeutics Drugs Sales by Type (2020-2025)
4.1.2 Global Protein Therapeutics Drugs Sales by Type (2026-2031)
4.1.3 Global Protein Therapeutics Drugs Sales Market Share by Type (2020-2031)
4.2 Global Protein Therapeutics Drugs Revenue by Type (2020-2031)
4.2.1 Global Protein Therapeutics Drugs Revenue by Type (2020-2025)
4.2.2 Global Protein Therapeutics Drugs Revenue by Type (2026-2031)
4.2.3 Global Protein Therapeutics Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Protein Therapeutics Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Protein Therapeutics Drugs Sales by Application (2020-2031)
5.1.1 Global Protein Therapeutics Drugs Sales by Application (2020-2025)
5.1.2 Global Protein Therapeutics Drugs Sales by Application (2026-2031)
5.1.3 Global Protein Therapeutics Drugs Sales Market Share by Application (2020-2031)
5.2 Global Protein Therapeutics Drugs Revenue by Application (2020-2031)
5.2.1 Global Protein Therapeutics Drugs Revenue by Application (2020-2025)
5.2.2 Global Protein Therapeutics Drugs Revenue by Application (2026-2031)
5.2.3 Global Protein Therapeutics Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Protein Therapeutics Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Johnson and Johnson
6.1.1 Johnson and Johnson Company Information
6.1.2 Johnson and Johnson Description and Business Overview
6.1.3 Johnson and Johnson Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Johnson and Johnson Protein Therapeutics Drugs Product Portfolio
6.1.5 Johnson and Johnson Recent Developments/Updates
6.2 Pfizer Inc
6.2.1 Pfizer Inc Company Information
6.2.2 Pfizer Inc Description and Business Overview
6.2.3 Pfizer Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Pfizer Inc Protein Therapeutics Drugs Product Portfolio
6.2.5 Pfizer Inc Recent Developments/Updates
6.3 F. Hoffmann La Roche Ltd
6.3.1 F. Hoffmann La Roche Ltd Company Information
6.3.2 F. Hoffmann La Roche Ltd Description and Business Overview
6.3.3 F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Product Portfolio
6.3.5 F. Hoffmann La Roche Ltd Recent Developments/Updates
6.4 Novo Nordisk AS
6.4.1 Novo Nordisk AS Company Information
6.4.2 Novo Nordisk AS Description and Business Overview
6.4.3 Novo Nordisk AS Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novo Nordisk AS Protein Therapeutics Drugs Product Portfolio
6.4.5 Novo Nordisk AS Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sanofi Protein Therapeutics Drugs Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Amgen Inc
6.6.1 Amgen Inc Company Information
6.6.2 Amgen Inc Description and Business Overview
6.6.3 Amgen Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Amgen Inc Protein Therapeutics Drugs Product Portfolio
6.6.5 Amgen Inc Recent Developments/Updates
6.7 Merck and Co., Inc
6.7.1 Merck and Co., Inc Company Information
6.7.2 Merck and Co., Inc Description and Business Overview
6.7.3 Merck and Co., Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Merck and Co., Inc Protein Therapeutics Drugs Product Portfolio
6.7.5 Merck and Co., Inc Recent Developments/Updates
6.8 Abbott Laboratories
6.8.1 Abbott Laboratories Company Information
6.8.2 Abbott Laboratories Description and Business Overview
6.8.3 Abbott Laboratories Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Abbott Laboratories Protein Therapeutics Drugs Product Portfolio
6.8.5 Abbott Laboratories Recent Developments/Updates
6.9 Baxter International Inc
6.9.1 Baxter International Inc Company Information
6.9.2 Baxter International Inc Description and Business Overview
6.9.3 Baxter International Inc Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Baxter International Inc Protein Therapeutics Drugs Product Portfolio
6.9.5 Baxter International Inc Recent Developments/Updates
6.10 Eli Lilly And Company
6.10.1 Eli Lilly And Company Company Information
6.10.2 Eli Lilly And Company Description and Business Overview
6.10.3 Eli Lilly And Company Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Eli Lilly And Company Protein Therapeutics Drugs Product Portfolio
6.10.5 Eli Lilly And Company Recent Developments/Updates
6.11 AbbVie
6.11.1 AbbVie Company Information
6.11.2 AbbVie Description and Business Overview
6.11.3 AbbVie Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.11.4 AbbVie Protein Therapeutics Drugs Product Portfolio
6.11.5 AbbVie Recent Developments/Updates
6.12 Novartis
6.12.1 Novartis Company Information
6.12.2 Novartis Description and Business Overview
6.12.3 Novartis Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Novartis Protein Therapeutics Drugs Product Portfolio
6.12.5 Novartis Recent Developments/Updates
6.13 Gilead Sciences
6.13.1 Gilead Sciences Company Information
6.13.2 Gilead Sciences Description and Business Overview
6.13.3 Gilead Sciences Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Gilead Sciences Protein Therapeutics Drugs Product Portfolio
6.13.5 Gilead Sciences Recent Developments/Updates
6.14 Bristol-Myers Squibb
6.14.1 Bristol-Myers Squibb Company Information
6.14.2 Bristol-Myers Squibb Description and Business Overview
6.14.3 Bristol-Myers Squibb Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Bristol-Myers Squibb Protein Therapeutics Drugs Product Portfolio
6.14.5 Bristol-Myers Squibb Recent Developments/Updates
6.15 Innovent
6.15.1 Innovent Company Information
6.15.2 Innovent Description and Business Overview
6.15.3 Innovent Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.15.4 Innovent Protein Therapeutics Drugs Product Portfolio
6.15.5 Innovent Recent Developments/Updates
6.16 AstraZeneca
6.16.1 AstraZeneca Company Information
6.16.2 AstraZeneca Description and Business Overview
6.16.3 AstraZeneca Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.16.4 AstraZeneca Protein Therapeutics Drugs Product Portfolio
6.16.5 AstraZeneca Recent Developments/Updates
6.17 Hengrui Medicine
6.17.1 Hengrui Medicine Company Information
6.17.2 Hengrui Medicine Description and Business Overview
6.17.3 Hengrui Medicine Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.17.4 Hengrui Medicine Protein Therapeutics Drugs Product Portfolio
6.17.5 Hengrui Medicine Recent Developments/Updates
6.18 Takeda
6.18.1 Takeda Company Information
6.18.2 Takeda Description and Business Overview
6.18.3 Takeda Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.18.4 Takeda Protein Therapeutics Drugs Product Portfolio
6.18.5 Takeda Recent Developments/Updates
6.19 Kanghong Pharma
6.19.1 Kanghong Pharma Company Information
6.19.2 Kanghong Pharma Description and Business Overview
6.19.3 Kanghong Pharma Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.19.4 Kanghong Pharma Protein Therapeutics Drugs Product Portfolio
6.19.5 Kanghong Pharma Recent Developments/Updates
6.20 Seagen
6.20.1 Seagen Company Information
6.20.2 Seagen Description and Business Overview
6.20.3 Seagen Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.20.4 Seagen Protein Therapeutics Drugs Product Portfolio
6.20.5 Seagen Recent Developments/Updates
6.21 Sobi
6.21.1 Sobi Company Information
6.21.2 Sobi Description and Business Overview
6.21.3 Sobi Protein Therapeutics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.21.4 Sobi Protein Therapeutics Drugs Product Portfolio
6.21.5 Sobi Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Protein Therapeutics Drugs Industry Chain Analysis
7.2 Protein Therapeutics Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Protein Therapeutics Drugs Production Mode & Process Analysis
7.4 Protein Therapeutics Drugs Sales and Marketing
7.4.1 Protein Therapeutics Drugs Sales Channels
7.4.2 Protein Therapeutics Drugs Distributors
7.5 Protein Therapeutics Drugs Customer Analysis
8 Protein Therapeutics Drugs Market Dynamics
8.1 Protein Therapeutics Drugs Industry Trends
8.2 Protein Therapeutics Drugs Market Drivers
8.3 Protein Therapeutics Drugs Market Challenges
8.4 Protein Therapeutics Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson and Johnson
Pfizer Inc
F Hoffmann La Roche Ltd
Novo Nordisk AS
Sanofi
Amgen Inc
Merck and Co Inc
Abbott Laboratories
Baxter International Inc
Eli Lilly and Company
AbbVie
Novartis
Gilead Sciences
Bristol–Myers Squibb
Innovent
Astrazeneca plc
Hengrui Medicine
Takeda
Kanghong Pharma
Seagen
SOBI
List of Tables
 Table 1. Global Protein Therapeutics Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Protein Therapeutics Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Protein Therapeutics Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Protein Therapeutics Drugs Sales (K Dose) of Key Manufacturers (2020-2025)
 Table 5. Global Protein Therapeutics Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Protein Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Protein Therapeutics Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Protein Therapeutics Drugs Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Protein Therapeutics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Protein Therapeutics Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Protein Therapeutics Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Protein Therapeutics Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Protein Therapeutics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Protein Therapeutics Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Protein Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Protein Therapeutics Drugs Sales by Region (2020-2025) & (K Dose)
 Table 18. Global Protein Therapeutics Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Protein Therapeutics Drugs Sales by Region (2026-2031) & (K Dose)
 Table 20. Global Protein Therapeutics Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Protein Therapeutics Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Protein Therapeutics Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Protein Therapeutics Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Protein Therapeutics Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Protein Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Protein Therapeutics Drugs Sales by Country (2020-2025) & (K Dose)
 Table 27. North America Protein Therapeutics Drugs Sales by Country (2026-2031) & (K Dose)
 Table 28. North America Protein Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Protein Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Protein Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Protein Therapeutics Drugs Sales by Country (2020-2025) & (K Dose)
 Table 32. Europe Protein Therapeutics Drugs Sales by Country (2026-2031) & (K Dose)
 Table 33. Europe Protein Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Protein Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Protein Therapeutics Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Protein Therapeutics Drugs Sales by Region (2020-2025) & (K Dose)
 Table 37. Asia Pacific Protein Therapeutics Drugs Sales by Region (2026-2031) & (K Dose)
 Table 38. Asia Pacific Protein Therapeutics Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Protein Therapeutics Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Protein Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Protein Therapeutics Drugs Sales by Country (2020-2025) & (K Dose)
 Table 42. Latin America Protein Therapeutics Drugs Sales by Country (2026-2031) & (K Dose)
 Table 43. Latin America Protein Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Protein Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Protein Therapeutics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Protein Therapeutics Drugs Sales by Country (2020-2025) & (K Dose)
 Table 47. Middle East and Africa Protein Therapeutics Drugs Sales by Country (2026-2031) & (K Dose)
 Table 48. Middle East and Africa Protein Therapeutics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Protein Therapeutics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Protein Therapeutics Drugs Sales (K Dose) by Type (2020-2025)
 Table 51. Global Protein Therapeutics Drugs Sales (K Dose) by Type (2026-2031)
 Table 52. Global Protein Therapeutics Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Protein Therapeutics Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Protein Therapeutics Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Protein Therapeutics Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Protein Therapeutics Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Protein Therapeutics Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Protein Therapeutics Drugs Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Protein Therapeutics Drugs Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Protein Therapeutics Drugs Sales (K Dose) by Application (2020-2025)
 Table 61. Global Protein Therapeutics Drugs Sales (K Dose) by Application (2026-2031)
 Table 62. Global Protein Therapeutics Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Protein Therapeutics Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Protein Therapeutics Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Protein Therapeutics Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Protein Therapeutics Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Protein Therapeutics Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Protein Therapeutics Drugs Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Protein Therapeutics Drugs Price (US$/Dose) by Application (2026-2031)
 Table 70. Johnson and Johnson Company Information
 Table 71. Johnson and Johnson Description and Business Overview
 Table 72. Johnson and Johnson Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Johnson and Johnson Protein Therapeutics Drugs Product
 Table 74. Johnson and Johnson Recent Developments/Updates
 Table 75. Pfizer Inc Company Information
 Table 76. Pfizer Inc Description and Business Overview
 Table 77. Pfizer Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. Pfizer Inc Protein Therapeutics Drugs Product
 Table 79. Pfizer Inc Recent Developments/Updates
 Table 80. F. Hoffmann La Roche Ltd Company Information
 Table 81. F. Hoffmann La Roche Ltd Description and Business Overview
 Table 82. F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. F. Hoffmann La Roche Ltd Protein Therapeutics Drugs Product
 Table 84. F. Hoffmann La Roche Ltd Recent Developments/Updates
 Table 85. Novo Nordisk AS Company Information
 Table 86. Novo Nordisk AS Description and Business Overview
 Table 87. Novo Nordisk AS Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Novo Nordisk AS Protein Therapeutics Drugs Product
 Table 89. Novo Nordisk AS Recent Developments/Updates
 Table 90. Sanofi Company Information
 Table 91. Sanofi Description and Business Overview
 Table 92. Sanofi Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 93. Sanofi Protein Therapeutics Drugs Product
 Table 94. Sanofi Recent Developments/Updates
 Table 95. Amgen Inc Company Information
 Table 96. Amgen Inc Description and Business Overview
 Table 97. Amgen Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 98. Amgen Inc Protein Therapeutics Drugs Product
 Table 99. Amgen Inc Recent Developments/Updates
 Table 100. Merck and Co., Inc Company Information
 Table 101. Merck and Co., Inc Description and Business Overview
 Table 102. Merck and Co., Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 103. Merck and Co., Inc Protein Therapeutics Drugs Product
 Table 104. Merck and Co., Inc Recent Developments/Updates
 Table 105. Abbott Laboratories Company Information
 Table 106. Abbott Laboratories Description and Business Overview
 Table 107. Abbott Laboratories Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 108. Abbott Laboratories Protein Therapeutics Drugs Product
 Table 109. Abbott Laboratories Recent Developments/Updates
 Table 110. Baxter International Inc Company Information
 Table 111. Baxter International Inc Description and Business Overview
 Table 112. Baxter International Inc Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 113. Baxter International Inc Protein Therapeutics Drugs Product
 Table 114. Baxter International Inc Recent Developments/Updates
 Table 115. Eli Lilly And Company Company Information
 Table 116. Eli Lilly And Company Description and Business Overview
 Table 117. Eli Lilly And Company Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 118. Eli Lilly And Company Protein Therapeutics Drugs Product
 Table 119. Eli Lilly And Company Recent Developments/Updates
 Table 120. AbbVie Company Information
 Table 121. AbbVie Description and Business Overview
 Table 122. AbbVie Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 123. AbbVie Protein Therapeutics Drugs Product
 Table 124. AbbVie Recent Developments/Updates
 Table 125. Novartis Company Information
 Table 126. Novartis Description and Business Overview
 Table 127. Novartis Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 128. Novartis Protein Therapeutics Drugs Product
 Table 129. Novartis Recent Developments/Updates
 Table 130. Gilead Sciences Company Information
 Table 131. Gilead Sciences Description and Business Overview
 Table 132. Gilead Sciences Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 133. Gilead Sciences Protein Therapeutics Drugs Product
 Table 134. Gilead Sciences Recent Developments/Updates
 Table 135. Bristol-Myers Squibb Company Information
 Table 136. Bristol-Myers Squibb Description and Business Overview
 Table 137. Bristol-Myers Squibb Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 138. Bristol-Myers Squibb Protein Therapeutics Drugs Product
 Table 139. Bristol-Myers Squibb Recent Developments/Updates
 Table 140. Innovent Company Information
 Table 141. Innovent Description and Business Overview
 Table 142. Innovent Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 143. Innovent Protein Therapeutics Drugs Product
 Table 144. Innovent Recent Developments/Updates
 Table 145. AstraZeneca Company Information
 Table 146. AstraZeneca Description and Business Overview
 Table 147. AstraZeneca Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 148. AstraZeneca Protein Therapeutics Drugs Product
 Table 149. AstraZeneca Recent Developments/Updates
 Table 150. Hengrui Medicine Company Information
 Table 151. Hengrui Medicine Description and Business Overview
 Table 152. Hengrui Medicine Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 153. Hengrui Medicine Protein Therapeutics Drugs Product
 Table 154. Hengrui Medicine Recent Developments/Updates
 Table 155. Takeda Company Information
 Table 156. Takeda Description and Business Overview
 Table 157. Takeda Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 158. Takeda Protein Therapeutics Drugs Product
 Table 159. Takeda Recent Developments/Updates
 Table 160. Kanghong Pharma Company Information
 Table 161. Kanghong Pharma Description and Business Overview
 Table 162. Kanghong Pharma Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 163. Kanghong Pharma Protein Therapeutics Drugs Product
 Table 164. Kanghong Pharma Recent Developments/Updates
 Table 165. Seagen Company Information
 Table 166. Seagen Description and Business Overview
 Table 167. Seagen Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 168. Seagen Protein Therapeutics Drugs Product
 Table 169. Seagen Recent Developments/Updates
 Table 170. Sobi Company Information
 Table 171. Sobi Description and Business Overview
 Table 172. Sobi Protein Therapeutics Drugs Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 173. Sobi Protein Therapeutics Drugs Product
 Table 174. Sobi Recent Developments/Updates
 Table 175. Key Raw Materials Lists
 Table 176. Raw Materials Key Suppliers Lists
 Table 177. Protein Therapeutics Drugs Distributors List
 Table 178. Protein Therapeutics Drugs Customers List
 Table 179. Protein Therapeutics Drugs Market Trends
 Table 180. Protein Therapeutics Drugs Market Drivers
 Table 181. Protein Therapeutics Drugs Market Challenges
 Table 182. Protein Therapeutics Drugs Market Restraints
 Table 183. Research Programs/Design for This Report
 Table 184. Key Data Information from Secondary Sources
 Table 185. Key Data Information from Primary Sources
 Table 186. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Protein Therapeutics Drugs
 Figure 2. Global Protein Therapeutics Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Protein Therapeutics Drugs Market Share by Type: 2024 & 2031
 Figure 4. Monoclonal Antibodies Product Picture
 Figure 5. Insulin Product Picture
 Figure 6. Fusion Protein Product Picture
 Figure 7. Erythropoietin Product Picture
 Figure 8. Interferon Product Picture
 Figure 9. Human Growth Hormone Product Picture
 Figure 10. Others Product Picture
 Figure 11. Global Protein Therapeutics Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 12. Global Protein Therapeutics Drugs Market Share by Application: 2024 & 2031
 Figure 13. Cancer
 Figure 14. Metabolic Disorders
 Figure 15. Immunologic Disorders
 Figure 16. Hematological Disorders
 Figure 17. Hormonal Disorders
 Figure 18. Genetic Disorders
 Figure 19. Others
 Figure 20. Global Protein Therapeutics Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 21. Global Protein Therapeutics Drugs Market Size (2020-2031) & (US$ Million)
 Figure 22. Global Protein Therapeutics Drugs Sales (2020-2031) & (K Dose)
 Figure 23. Global Protein Therapeutics Drugs Average Price (US$/Dose) & (2020-2031)
 Figure 24. Protein Therapeutics Drugs Report Years Considered
 Figure 25. Protein Therapeutics Drugs Sales Share by Manufacturers in 2024
 Figure 26. Global Protein Therapeutics Drugs Revenue Share by Manufacturers in 2024
 Figure 27. Global 5 and 10 Largest Protein Therapeutics Drugs Players: Market Share by Revenue in Protein Therapeutics Drugs in 2024
 Figure 28. Protein Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 29. Global Protein Therapeutics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 30. North America Protein Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 31. North America Protein Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 32. United States Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Canada Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Europe Protein Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 35. Europe Protein Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 36. Germany Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. France Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. U.K. Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Italy Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Russia Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Asia Pacific Protein Therapeutics Drugs Sales Market Share by Region (2020-2031)
 Figure 42. Asia Pacific Protein Therapeutics Drugs Revenue Market Share by Region (2020-2031)
 Figure 43. China Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Japan Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. South Korea Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. India Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Australia Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. China Taiwan Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Southeast Asia Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Latin America Protein Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 51. Latin America Protein Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 52. Mexico Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Brazil Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Argentina Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Colombia Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Middle East and Africa Protein Therapeutics Drugs Sales Market Share by Country (2020-2031)
 Figure 57. Middle East and Africa Protein Therapeutics Drugs Revenue Market Share by Country (2020-2031)
 Figure 58. Turkey Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 59. Saudi Arabia Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 60. UAE Protein Therapeutics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 61. Global Sales Market Share of Protein Therapeutics Drugs by Type (2020-2031)
 Figure 62. Global Revenue Market Share of Protein Therapeutics Drugs by Type (2020-2031)
 Figure 63. Global Protein Therapeutics Drugs Price (US$/Dose) by Type (2020-2031)
 Figure 64. Global Sales Market Share of Protein Therapeutics Drugs by Application (2020-2031)
 Figure 65. Global Revenue Market Share of Protein Therapeutics Drugs by Application (2020-2031)
 Figure 66. Global Protein Therapeutics Drugs Price (US$/Dose) by Application (2020-2031)
 Figure 67. Protein Therapeutics Drugs Value Chain
 Figure 68. Channels of Distribution (Direct Vs Distribution)
 Figure 69. Bottom-up and Top-down Approaches for This Report
 Figure 70. Data Triangulation
 Figure 71. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions